Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Air Methods (airm) -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (799)	11/3/1999 7:34:00 AM
From: Annie	Respond to of 877

Air Methods Retains Advisor to Evaluate Aerospace Technology Acquisitions DENVER, Nov. 3 /PRNewswire/ -- Air Methods Corporation (Nasdaq: AIRM) Products Division announced that it retained mergers and acquisitions specialist, Emerge Corporation (http://www.emergecorp.com), to assist in developing its acquisition strategy and target identification to expand the Division's rapidly growing aerospace technology products business. With offices in Costa Mesa, CA, Seattle, WA, and Chicago, IL, Emerge specializes in middle market transactions and is an affiliate of Pacific Mezzanine Investors who manage a $260 million fund for investment. George W. Belsey, Chairman and CEO, said, "We are very pleased to have engaged Emerge's expertise to assist with this M&A process. This initiative will complement and leverage the Division's already strong organic growth in an effort to achieve a $50 million revenue target in five years." Michael G. Prieto, Vice President of the Products Division, said, "Since the Division was created in 1994, we have become a global leader in providing technology solutions for the air medical transportation market. We are a key subcontractor providing the Multi-Mission Medevac System for the U.S. Army's UH-60Q Program potentially yielding revenue for Air Methods in excess of $150 million over the next twenty years. In addition, the Products Division is also the prime contractor for the development and manufacture of the U.S. Air Force's Spinal Cord Injury Transport System." As a result, Ronald J. Speyer, Chairman and CEO of Emerge, said "We are very excited about the opportunity to assist Air Methods in evaluating opportunities for diversification within the multi-billion dollar aerospace market. With the ongoing consolidation of the aerospace industry, a timely opportunity has been created for the right kind of middle market companies to become primary suppliers in a lucrative, worldwide industry." Air Methods Corporation (http://www.airmethods.com) is a leader in emergency aeromedical transportation, medical services and technology. The Flight Services Division is one of the largest providers of air medical transport services for hospitals. The Mercy Air subsidiary is one of the largest independent providers of air medical services. The Products Division specializes in the design and manufacture of aeromedical technology. The Company's fleet of owned, leased or maintained aircraft features 44 helicopters and 6 fixed wing aircraft. Forward-Looking Statements: This release includes certain forward-looking statements, which are subject to various risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including but not limited to the size, structure and growth of the Company's flight services and products markets; the continuation and/or renewal of flight service contracts; the acquisition of new and profitable Products Division contracts and other flight service operations; the expansion of Mercy Air operations; and other matters. CONTACT: Michael G. Prieto, Vice President, Air Methods, 303-792-7484; or Joe Gerber, Regional Managing Director of Emerge, 714-445-5940; or Investor & Media, Kimberly Ferro, 212-889-1727 ext. 106 or Gary Fishman, 212-889-1727 ext. 110, Investor Relations for Air Methods.